Antibody landscapes after influenza virus infection or vaccination
Judith M. Fonville(University of Cambridge), Derek J. Smith(Los Alamos National Laboratory), Tommy Kaplan(Queen Mary University of London), Malet Aban(Victorian Infectious Diseases Reference Laboratory), Lumin Xue(Victorian Infectious Diseases Reference Laboratory), Colin A. Russell(University of Amsterdam), Albert D. M. E. Osterhaus(Erasmus MC), Phạm Quang Thái(National Institute Of Hygiene And Epidemiology), Annette Fox(MRC Unit the Gambia), Aeron C. Hurt(The University of Melbourne), Samuel Wilks(University of Cambridge), A.M. Palache(Abbott (United Kingdom)), Nam Tran(Moffitt Cancer Center), Le Quellec-Nathan M(National Institute Of Hygiene And Epidemiology), Ron A. M. Fouchier(Erasmus MC), W.E.P. Beyer(Erasmus MC), Leah C. Katzelnick(National Institutes of Health), Terry C. Jones(Centers for Disease Control and Prevention), Ana Mosterín(Centers for Disease Control and Prevention), N. Masurel(Erasmus MC), Heiman Wertheim, Mariangela Ventresca(University of Cambridge), Sarah L. James(University of Cambridge), Peter Horby, Eugene Skepner(University of Cambridge), J.C. de Jong(Erasmus MC), Guus F. Rimmelzwaan(University of Veterinary Medicine Hannover, Foundation), Guido van der Net(Erasmus MC), Ian Barr(Centers for Disease Control and Prevention), Le Tao(National Institute Of Hygiene And Epidemiology), Nguyễn Thanh Hải(National Institute Of Hygiene And Epidemiology), Le N. M. H.(National Institute Of Hygiene And Epidemiology), David Labonte(University of Cambridge)
Cited by 514
Related Papers
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
|New England Journal of Medicine|2012|6k
Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome
|New England Journal of Medicine|2003|4.8k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k